Athenex (NASDAQ: ATNX)
FY 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-12-20 | ||||||
REV |
FY 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-11-09 | ||||||
REV |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Athenex (NASDAQ: ATNX) through any online brokerage.
Other companies in Athenex’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Virios Therapeutics (NASDAQ:VIRI), Evaxion Biotech (NASDAQ:EVAX), Aligos Therapeutics (NASDAQ:ALGS) and Geovax Labs (NASDAQ:GOVX).
The latest price target for Athenex (NASDAQ: ATNX) was reported by Cantor Fitzgerald on Friday, August 12, 2022. The analyst firm set a price target for 4.00 expecting ATNX to rise to within 12 months (a possible 669.23% upside). 50 analyst firms have reported ratings in the last year.
The stock price for Athenex (NASDAQ: ATNX) is $0.52 last updated August 12, 2022, 8:00 PM UTC.
The next Athenex (ATNX) dividend date is projected to be Thursday, September 1, 2022.
Athenex’s FY earnings are confirmed for Wednesday, December 20, 2023.
There is no upcoming split for Athenex.
Athenex is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.